The Hepatocellular Carcinoma Early Detection Screening (HES) algorithm, which includes age, AFP, rate of AFP change, ALT, and platelet count, was validated in a phase II study in HCV-related HCC. This evidence concerns the gene AFP and hepatocellular carcinoma.